Vetted Providers

Strongest compliance posture in our initial GLP-1 cohort. LegitScript-certified at both the platform and pharmacy level, with transparent pricing and no major regulatory issues on record. Worth considering as a default option for users prioritizing cleaner sourcing over absolute lowest price.

Hone Health is our top pick in hormone-TRT for most users. The trust signals are uniformly positive: BBB Accredited (relatively recent, Dec 2023), Trustpilot 4.8 across 10,000+ reviews with no fraud notice, no FDA warning letters, and a care model that requires baseline labs before prescribing (the right clinical standard). Pricing isn't the cheapest, but the all-in math at $157-$249/month with labs bundled from month three is honest and competitive. Choose Defy Medical if you specifically want MD/DO physicians with endocrinology backgrounds and are willing to pay premium pricing for that depth; choose Marek Health if you want the coaching-plus-prescribing model.

Function Health is our top pick in DTC lab-testing-for-longevity. The $365/year price is genuinely competitive for two annual full panels with MD review of every biomarker, the panel breadth is among the largest in the category (160+ tests, 100+ biomarkers per draw), and Mark Hyman as clinical face plus the recent $298M raise at $2.5B valuation provide unusual operational depth for a DTC lab service. Counterweights are real but manageable: BBB NOT Accredited, recurring complaints about customer-support response time and unclear add-on pricing. For most readers wanting comprehensive lab-testing context for longevity decisions, this is the default recommendation.

InsideTracker is a credible alternative to Function Health for DTC biomarker testing, with three differentiators that matter: a 15-year track record (founded circa 2009), peer-reviewed methodology research published in PubMed Central, and the strongest customer-service responsiveness signal in our lab-testing cohort (94% reply rate to negative Trustpilot reviews within one week). The honest counterweight: Function Health is meaningfully cheaper on a panel-per-dollar basis ($365/year for 100+ markers per draw twice a year vs InsideTracker's roughly $489-$829/year for 1-2 Ultimate tests at 54 markers each). Choose InsideTracker if you want the DNA add-on, smaller targeted panels, or the company's longer track record and customer-service responsiveness; choose Function for the broadest panel at the lowest annual cost.

Eden has the most ambitious supply-chain story in our cohort, they own the pharmacy that fills your prescription, with a publicized per-lot testing program. The catch is the gap between the marketing and the operational record. BBB shows real complaint patterns around billing and refunds, ConsumerAffairs reinforces those themes, and a class-action investigation is examining whether Eden has been sharing health data with third-party advertisers. We list Eden because the structural advantages are real, but we score the experience-side dimensions honestly. If supply-chain integrity matters more to you than billing predictability, this is a contender. If you want predictable cancellation and refund handling, look elsewhere.

The strongest pick in our cohort for users with commercial insurance, hands down. The insurance concierge is a genuine differentiator: on Wegovy or Zepbound with eligible coverage and a manufacturer savings card, your monthly cost drops to $0-$25, which no all-inclusive cash-pay specialist can match. The catch is the multi-product compounder relationship: the April 2025 FDA finasteride alert reflects on Ro's vendor management broadly, and BBB complaints about membership-vs-medication billing transparency are recurring. Pure cash-pay users on compounded GLP-1 will find better value at TrimRx or Eden.

Defy Medical is the premium pick in hormone-TRT for users who specifically want MDs and DOs with endocrinology backgrounds and willingness to customize protocols beyond standard monotherapy. The physician-credential signal is the strongest in our cohort. The honest counterweights are real: BBB C rating with one unanswered complaint, recurring forum threads about refill delays, and pricing that runs $200-$350/month all-in vs Hone's $157-$249. Choose Defy if you've outgrown a basic TRT protocol and want depth; choose Hone Health if you want the cleaner trust posture and lower price.

If you specifically want a brand-name GLP-1 from a public-company telehealth platform with mature compliance infrastructure, post-settlement Hims is a credible option, especially for the new oral Wegovy pill. The insurance pathway can drive Wegovy to $0-$25/month with eligible coverage. The honest counterweight: the September 2025 FDA warning letters and the messy 2025 break with Novo Nordisk are both recent enough that we are docking the score below where a clean operator would land. Trustpilot at 3.0/5 with 28% one-star reviews is worse than Ro's, and the BBB A+ does not fully offset that. For pure cash-pay compounded GLP-1, Hims no longer competes (compounded is wound down post-settlement); look at TrimRx or Eden.

Marek Health is a credible third option in hormone-TRT for users who specifically want the coaching-plus-prescribing model. The Trustpilot signal is consistent (4.8 across the smaller sample), the pricing is mid-range, and the lab-heavy approach is appropriate for hormone optimization. The honest counterweights: NOT BBB-accredited with no posted letter grade, smaller operational scale than Hone or Defy, and the all-in cost lands above Hone once you factor quarterly lab fees. Choose Hone for most cases; Marek if monthly coaching contact between provider visits is the binding need.

Tally Health is a credible biological-age testing service for users specifically interested in the epigenetic age question, with David Sinclair's name behind the methodology and a transparent membership pricing model. The honest counterweights are real: small Trustpilot sample (only 37 reviews, 3.6/5), recurring complaints about result-delivery delays running 9+ weeks vs the advertised 2-4, and the recent April 2026 acquisition by Infinite Epigenetics adding operational uncertainty. For most users wanting longevity-context lab data, Function Health's broader panel at comparable price is the better default; Tally only makes sense if you specifically want the epigenetic age metric.

Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol (4x total testosterone and 5x free testosterone with LH/FSH preserved on the Oral T + Enclomiphene approach), which is a meaningful clinical-transparency advantage. The fertility-preservation angle is also genuinely differentiating for younger men or those concerned about fertility on traditional injectable TRT. Honest counterweights are real and stack: BBB F rating driven by unanswered complaints (structurally similar to Henry Meds's failure mode), small Trustpilot sample relative to cohort competitors, and a broader compounded-medication footprint that extends beyond TRT into GLP-1 and other categories. Choose Maximus if fertility-preserving oral TRT is specifically the binding need and you've read the BBB complaint pattern and decided you're comfortable with the operational risk; otherwise Hone Health remains the cleaner default for hormone-TRT.

Mochi Health is the most complicated provider in our cohort to score. The consumer-experience signal is strong (Trustpilot 4.4/5 across 15,600+ reviews with no fraud notice, board-certified obesity-medicine physicians, genuinely innovative flat-rate dose-independent pricing) and the FDA record is clean. The counterweight is heavy and substantively different from anything else in our cohort: Washington State pharmacy enforcement against Mochi's affiliated compounding pharmacy Aequita escalated to a Notice of Immediate Jeopardy after whistleblower allegations of unlicensed-worker sterile compounding and improper cold-chain shipping (frozen children's popsicles instead of medical-grade ice packs). Two active manufacturer lawsuits compound the picture. We list Mochi because the pricing model is genuinely interesting and the consumer experience is broadly positive, but we cannot recommend Mochi as a default option for any cohort segment given the substantiated pharmacy-quality concerns. Choose Mochi only if the flat-rate dose-independent pricing is specifically what you want and you have read the WA State enforcement record and decided you are comfortable with it.

If pure cash price is the only thing that matters and you're going in eyes wide open on the trust caveats, Henry Meds is the cohort's discount option, by a wide margin on oral semaglutide and oral tirzepatide. The honest counterweights are heavy: an F at the BBB with 25 unanswered complaints, a Trustpilot page that carries a suspected-fake-review notice (so the 4.5-star headline does not mean what it appears to mean), and an active Eli Lilly lawsuit over the way the company markets compounded tirzepatide. We list Henry Meds because the price difference is real for cost-sensitive readers, but the trust premium is on you. For most readers, TrimRx or Eden is the better starting point even if the monthly cost is higher.